Duration of anticoagulation: decision making based on absolute risk

This publication has 23 references indexed in Scilit:

• Risk Factors of Recurrent Venous Thromboembolism: The Role of Residual Vein Thrombosis
  Pathophysiology of Haemostasis and Thrombosis, 2003
• Individualized duration of oral anticoagulant therapy for deep vein thrombosis based on a decision model
  Journal of Thrombosis and Haemostasis, 2003
• Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study
  The Lancet, 2003
• Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism
  Annals of Internal Medicine, 2002
• Risk of Deep Vein Thrombosis Recurrence: High Negative Predictive Value of D-dimer Performed during Oral Anticoagulation
  Thrombosis and Haemostasis, 2002
• A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism
  New England Journal of Medicine, 1999
• Long-Term Treatment of Venous Thromboembolic Disease
  Thrombosis and Haemostasis, 1999
• The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism
  New England Journal of Medicine, 1997
• A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism
  New England Journal of Medicine, 1995
• ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISM
  The Lancet, 1960